140 related articles for article (PubMed ID: 32603222)
1. Whole-Body Bone Scintigraphy Helps to Detect Kidney Diseases.
Zhao C; Long X; Zhou K; Zhou J; Zhao C; Cao L; Jia Z
AJR Am J Roentgenol; 2021 Jan; 216(1):172-185. PubMed ID: 32603222
[TBL] [Abstract][Full Text] [Related]
2. Accurate characterization of
Zhang L; He Q; Zhou T; Zhang B; Li W; Peng H; Zhong X; Ma L; Zhang R
BMC Med Imaging; 2019 May; 19(1):44. PubMed ID: 31146746
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Insufficiency Fracture After Radiotherapy in Patients With Cervical Cancer: Contribution of Technetium Tc 99m-Labeled Methylene Diphosphonate Single-Photon Emission Computed Tomography/Computed Tomography.
Zhang L; He Q; Jiang M; Zhang B; Zhong X; Zhang R
Int J Gynecol Cancer; 2018 Sep; 28(7):1369-1376. PubMed ID: 30095704
[TBL] [Abstract][Full Text] [Related]
5. Increased renal retention of 99mTc-methylene diphosphonate after nephron-sparing surgery.
Inoue Y; Ohtake T; Kameyama S; Yamazaki S; Kawabe K; Yoshikawa K; Nishikawa J; Sasaki Y
J Nucl Med; 1999 Mar; 40(3):418-21. PubMed ID: 10086705
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-N,N-ethylenedicysteine and Tc-99m DMSA scintigraphy in the evaluation of renal parenchymal abnormalities in children.
Kibar M; Yapar Z; Noyan A; Anarat A
Ann Nucl Med; 2003 May; 17(3):219-25. PubMed ID: 12846544
[TBL] [Abstract][Full Text] [Related]
7. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective study of renal images on bone scans].
Murayama T; Munakata A; Narita K; Fujita K; Fujii K
Rinsho Hoshasen; 1989 Mar; 34(3):335-8. PubMed ID: 2739084
[TBL] [Abstract][Full Text] [Related]
9. Comparative whole-body 201Tl and bone scintigraphies for the detection of bone marrow involvement in multiple myeloma.
Nishiyama Y; Yamamoto Y; Nagai M; Satoh K; Ohkawa M
Nucl Med Commun; 2003 Sep; 24(9):977-86. PubMed ID: 12960597
[TBL] [Abstract][Full Text] [Related]
10. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
[TBL] [Abstract][Full Text] [Related]
11. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-dimercaptosuccinic acid renal scintigraphy can guide clinical management in congenital hydronephrosis.
Bazić-Đorović B; Radulović M; Šišić M; Jauković L; Dugonjić S; Pucar D; Janković Z; Beatović S; Janković M; Krstić Z; Ajdinović B
Hell J Nucl Med; 2017; 20 Suppl():114-122. PubMed ID: 29324920
[TBL] [Abstract][Full Text] [Related]
13. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
14. [Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].
Seto K
Rinsho Hoshasen; 1989 Nov; 34(12):1433-6. PubMed ID: 2593286
[TBL] [Abstract][Full Text] [Related]
15. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
16. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
[TBL] [Abstract][Full Text] [Related]
17. Bone scintigraphy in acute renal failure with severe loin pain and patchy renal vasoconstriction.
Han JS; Kim YG; Kim S; Lee MC; Lee JS; Kim SH
Nephron; 1991; 59(2):254-60. PubMed ID: 1835520
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.
Van Laere K; Casier K; Uyttendaele D; Mondelaers W; De Sadeleer C; Simons M; Dierckx R
J Nucl Med; 1998 Sep; 39(9):1563-9. PubMed ID: 9744344
[TBL] [Abstract][Full Text] [Related]
19. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
[TBL] [Abstract][Full Text] [Related]
20. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
